The company’s operating profit also dipped 4.4 percent from last year, ending the quarter at $241 million.
In its financial report, the orthopedic device manufacturer announced a $300 million share buyback program as part of a new “capital allocation framework.”
More Articles on Devices:
Smith & Nephew to Acquire India-Based Orthopedic Trauma Device Developer
NuVasive Gross Profits Up 4.9% in Q1
Alphatec Spine Gross Profits Increase 2.9% in Q1
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
